Adagene
Adagene's Overview
Adagene Inc. is a clinical-stage, platform-driven biotechnology company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Leveraging its proprietary Dynamic Precision Library (DPL) and SAFEbody® precision masking technology platforms, Adagene designs and generates differentiated antibody therapeutics with enhanced efficacy and safety profiles. The company is focused on building a robust pipeline of potential first-in-class or best-in-class medicines to address unmet medical needs in oncology globally.
Where is Adagene's Headquarters?
HQ Function
Serves as the central hub for global operations, research and development, strategic planning, and corporate governance.
Notable Features:
Located within BioBay, a premier biopharmaceutical innovation park, providing access to state-of-the-art facilities, a collaborative research environment, and a skilled talent pool.
Work Culture:
Fosters a dynamic and innovative work environment focused on scientific excellence, collaboration, and a commitment to developing transformative cancer therapies. Employees are driven by a shared mission to impact patient lives.
HQ Significance:
The Suzhou headquarters anchors Adagene's operations in a rapidly growing biotech ecosystem, facilitating access to research talent, manufacturing capabilities, and the Asia-Pacific market. It's key to their global R&D strategy.
Values Reflected in HQ: The location and setup reflect Adagene's commitment to cutting-edge research, global collaboration, and strategic growth in the biopharmaceutical sector.
Location:
Adagene supports its global R&D, clinical development, and business operations through its headquarters in Suzhou, China, a major U.S. hub in San Diego, California, and an office in Shanghai. This strategically distributed presence enables the company to conduct global clinical trials, engage with international regulatory agencies, foster worldwide collaborations, and access diverse talent pools to advance its pipeline of innovative cancer immunotherapies.
Street Address:
BioBay, 218 Xinghu Street, Building A4, Suite 408-409
City:
Suzhou
State/Province:
Jiangsu
Country:
China
Adagene's Global Presence
San Diego, California/USA
Address: 10188 Telesis Court, Suite F, San Diego, CA 92121, USA
Supports engagement with the U.S. regulatory bodies (FDA), clinical research organizations, and the North American investment community. Crucial for global clinical trial management and business expansion.
Shanghai, China
Address: Building 3, No.665 Shanghai Ludi, Pudong, Shanghai, China
Strengthens Adagene's presence in another key Chinese metropolitan area, supporting clinical activities and collaborations within China.
Buying Intent Signals for Adagene
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Adagene
As of April 2025, Adagene' leadership includes:
Investors of Adagene
Adagene has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the past 12 months, Adagene notably strengthened its financial leadership with the appointment of a new Chief Financial Officer. This key hire supports the company's strategic financial planning and growth initiatives as it advances its clinical pipeline.
Departures
New Appointments:
Technology (Tech Stack) used by Adagene
Discover the tools Adagene uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Adagene Email Formats and Examples
Adagene likely utilizes common corporate email patterns, often combining first name, last name, or initials with their domain '@adagene.com'. While the exact primary format isn't publicly disclosed, typical structures for biotech companies include [first_initial][last]@adagene.com or [first].[last]@adagene.com.
[first_initial][last]@adagene.com
Format
pluo@adagene.com
Example
75%
Success rate
News and media
Adagene Inc. / GlobeNewswire • April 8, 2024
Adagene Presents Preclinical Data for Anti-CTLA-4 SAFEbody® ADG126 (NEOKIN-2/15™) at AACR 2024 Annual Meeting
Adagene announced the presentation of preclinical data for its masked, conditionally activated anti-CTLA-4 SAFEbody®, ADG126, combined with its IL-2/IL-15 Fc fusion protein (NEOKIN-2/15™), at the American Association for Cancer Research (AACR) Annual Meeting 2024. The data highlighted enhanced anti-tumor activity and improved safety profile....more
Adagene Inc. / GlobeNewswire • December 18, 2023
Adagene Announces First Patient Dosed in Phase 1b/2 Clinical Trial of ADG153 in Combination with Pembrolizumab for Advanced Solid Tumors
Adagene reported that the first patient has been dosed in its Phase 1b/2 clinical trial evaluating ADG153, an anti-CD20xCD3 bispecific T-cell engager, in combination with pembrolizumab for patients with advanced solid tumors. This marks progress in their clinical development pipeline....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Adagene, are just a search away.